Previously published data has indicated a downregulation of PI3K pathway signalling in cisplatin-resistant NSCLC, where GDC-0980 was shown to induce a correspondingly weaker effect than that seen in cisplatin sensitive cells [32]. Here, PIK3CA is linked to non-small cell lung carcinoma.